Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Christian Flössner"'
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 10, Iss 9, Pp 3283-3287 (2021)
Introduction: Preventing human immunodeficiency virus (HIV) infection is central to containing the HIV pandemic. For pre- and post-exposure prophylaxis (PrEP and PEP), drugs approved in Germany are available. Basic information on this should be obtai
Externí odkaz:
https://doaj.org/article/a1e29498f7e3444e90590615b72dc92b
Publikováno v:
Das Gesundheitswesen. 83:1015-1018
Zusammenfassung Einleitung Die HIV-PrEP (HIV-Prä-Expositionsprophylaxe) ist seit 2017 über deutsche Apotheken in unterschiedlichen Abpackungen erhältlich. Sie ist entweder als tägliche Einnahme oder als intermittierende, anlassbezogene Einnahme a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df1b78fcf27f140591bf70b6a869f44f
https://doi.org/10.1055/a-1162-8308
https://doi.org/10.1055/a-1162-8308
Autor:
Juliane Ankert, Christian Flössner, Alexandra Jablonka, Steve Rößler, Benjamin T. Schleenvoigt
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 144:1158-1165
According to the Robert Koch Institute, the estimated HIV prevalence in Germany is 86 100. On-third of the affected persons is over 50 years old. Overall, the prognosis of patients with HIV infection depends crucially on the time of diagnosis. The un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a6e128302b21627c75409390dee426c
https://doi.org/10.1055/a-0813-3850
https://doi.org/10.1055/a-0813-3850
Publikováno v:
Journal of Family Medicine and Primary Care
Journal of Family Medicine and Primary Care, Vol 10, Iss 9, Pp 3283-3287 (2021)
Journal of Family Medicine and Primary Care, Vol 10, Iss 9, Pp 3283-3287 (2021)
Introduction: Preventing human immunodeficiency virus (HIV) infection is central to containing the HIV pandemic. For pre- and post-exposure prophylaxis (PrEP and PEP), drugs approved in Germany are available. Basic information on this should be obtai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be3bf0a9fb3c30366a07ba2bfcd1bd2c
https://pubmed.ncbi.nlm.nih.gov/34760745
https://pubmed.ncbi.nlm.nih.gov/34760745
Publikováno v:
Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)). 83(12)
HIV-PrEP (HIV-Pre-Exposure Prophylaxis) has been available through German pharmacies in various package sizes since 2017. It can be used for daily dosing or as an intermittent product used as required.The aim of this survey was to record socio-demogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::92a36070769611cdc30c7e813c4f87e6
https://pubmed.ncbi.nlm.nih.gov/32894874
https://pubmed.ncbi.nlm.nih.gov/32894874
Autor:
Juliane, Ankert, Steve, Rößler, Christian, Flössner, Alexandra, Jablonka, Benjamin T, Schleenvoigt
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 144(16)
According to the Robert Koch Institute, the estimated HIV prevalence in Germany is 86 100. On-third of the affected persons is over 50 years old. Overall, the prognosis of patients with HIV infection depends crucially on the time of diagnosis. The un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f665a9c71be3056b7a9702c2fec7183
https://pubmed.ncbi.nlm.nih.gov/31416108
https://pubmed.ncbi.nlm.nih.gov/31416108